Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Country Report

Rx/Reimbursement adult incontinence in

Rx/Reimbursement Adult Incontinence in Norway

Jun 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PRE-COVID-19 PERFORMANCE

Ageing population and rising obesity levels drive growth in 2019

Similar to retail adult incontinence, growth in Rx/reimbursement adult incontinence in 2019 was driven by a natural increase in demand arising from an ageing population and rising obesity rate. Norway’s reimbursement mechanism is called the “blue receipt” and applies to all diseases and medications.

Taboos remain as producers seek visibility through marketing efforts in 2019

Adult incontinence continued to be a largely taboo subject in Norway, with sufferers commonly feeling a sense of shame or embarrassment in seeking help. Some adults therefore continued to choose to forgo the medical assessment route and the reimbursement scheme for incontinence products.

Essity and Attends retain lead in 2019 and restrict opportunities for new players

Similar to retail and away-from-home sales of incontinence products, Essity and Attends remained the leading players with their respective Tena and Attends brands in 2019. These are typically the only incontinence brands offered by pharmacy chains.

2020 AND BEYOND

COVID-19 impact

Sales of Rx/reimbursement adult incontinence are expected to grow by 7% in 2019 constant value terms in 2020 overall in light of the impact of COVID-19.

Recovery and opportunities

Rx/reimbursement adult incontinence is expected to see solid growth during the forecast period. Any product shortages during the early stages of the COVID-19 pandemic are likely to be temporary.

Files are delivered directly into your account within a few minutes of purchase.

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

SAMPLES

FAQS ABOUT SAMPLES

DELIVERY

Files are delivered directly into your account within a few minutes of purchase.

OVERVIEW

Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement adult incontinence industry in Norway with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Rx/Reimbursement adult incontinence industry in Norway, our research will save you time and money while empowering you to make informed, profitable decisions.

The Rx/Reimbursement adult incontinence in Norway market research report includes:

Analysis of key supply-side and demand trends
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Rx/Reimbursement adult incontinence in Norway?
What are the major brands in Norway?
What are the most important channels for Rx/Reimbursement adult incontinence products?
How do light incontinence products perform compared to moderate/heavy incontinence products?

WHY BUY THIS REPORT?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our

Tissue and Hygiene market research database

Want to find out more about this report?

Request more information

Rx/Reimbursement Adult Incontinence in Norway - Category analysis

HEADLINES

PRE-COVID-19 PERFORMANCE

Ageing population and rising obesity levels drive growth in 2019

Taboos remain as producers seek visibility through marketing efforts in 2019

Essity and Attends retain lead in 2019 and restrict opportunities for new players

2020 AND BEYOND

COVID-19 impact

Recovery and opportunities

CATEGORY DATA

Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2014-2019
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2014-2019
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2019-2024
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2019-2024

Tissue and Hygiene in Norway - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on tissue and hygiene

COVID-19 country impact

Sophisticated consumer demands and values drive product developments in 2019

Metsä Tissue and Essity maintain lead in 2019 against strong private label share

Preventative health to boost value performance post-COVID-19 against limited growth opportunities in a mature market

Chart 1 Tissue and Hygiene Value Sales Growth Scenarios: 2017-2024
Chart 2 Tissue and Hygiene Impact of Soft Drivers on Value Sales: 2016-2024

MARKET INDICATORS

Table 5 Birth Rates 2014-2019
Table 6 Infant Population 2014-2019
Table 7 Female Population by Age 2014-2019
Table 8 Total Population by Age 2014-2019
Table 9 Households 2014-2019
Table 10 Forecast Infant Population 2019-2024
Table 11 Forecast Female Population by Age 2019-2024
Table 12 Forecast Total Population by Age 2019-2024
Table 13 Forecast Households 2019-2024

MARKET DATA

Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2014-2019
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2014-2019
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2015-2019
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2016-2019
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2014-2019
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2014-2019
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2019
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2019-2024
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2019-2024

Megatrends

Country Report

Rx/Reimbursement Adult Incontinence in Norway

New Report Guarantee

Executive Summary

New Report Guarantee

PRE-COVID-19 PERFORMANCE

Ageing population and rising obesity levels drive growth in 2019

Taboos remain as producers seek visibility through marketing efforts in 2019

Essity and Attends retain lead in 2019 and restrict opportunities for new players

2020 AND BEYOND

COVID-19 impact

Recovery and opportunities

Overview

Why buy this report?

SAMPLES

DELIVERY

OVERVIEW

WHY BUY THIS REPORT?

Want to find out more about this report?

Table of Contents

Rx/Reimbursement Adult Incontinence in Norway - Category analysis

HEADLINES

PRE-COVID-19 PERFORMANCE

Ageing population and rising obesity levels drive growth in 2019

Taboos remain as producers seek visibility through marketing efforts in 2019

Essity and Attends retain lead in 2019 and restrict opportunities for new players

2020 AND BEYOND

COVID-19 impact

Recovery and opportunities

CATEGORY DATA

Tissue and Hygiene in Norway - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on tissue and hygiene

COVID-19 country impact

Sophisticated consumer demands and values drive product developments in 2019

Metsä Tissue and Essity maintain lead in 2019 against strong private label share

Preventative health to boost value performance post-COVID-19 against limited growth opportunities in a mature market

MARKET INDICATORS

MARKET DATA

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Recently Viewed

Complete Catalogue

Country Reports